L'Oreal Q1 2026 Results Lift Shares

L'Oreal Q1 2026 Results topped expectations with 6.7% adjusted like-for-like sales, boosted by the Kering Beauté close; shares jumped about 8-9%.

April 23, 2026·2 min read
View all news articles
Flat vector makeup compact unfolding petals to signal expansion after L'Oreal Q1 2026 Results.

KEY TAKEAWAYS

  • Adjusted like-for-like sales grew 6.7% in Q1 2026.
  • Reported like-for-like growth reached 7.6% with a 3.4% IT-phasing boost.
  • Shares rose about 8-9% following results and JPMorgan raised full-year sales growth to 4.8%.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

L'Oreal’s first-quarter 2026 results showed stronger-than-expected organic sales growth. After completing the Kering Beauté acquisition on March 31, 2026, management expressed optimism for full-year sales and profit despite geopolitical challenges.

Organic Growth and Division Performance

The company said in a press release on April 22, 2026, that adjusted like-for-like sales growth for the quarter was 6.7%, while reported like-for-like growth reached 7.6%. Total sales rose to €12.2 billion from €11.7 billion a year earlier. The difference between reported and adjusted growth reflected a 3.4% boost from the phasing of an IT-transformation program.

Divisional adjusted like-for-like growth was led by Professional Products at 13.1% and Dermatological Beauty at 10.2%. Luxe increased 5.6%, and Consumer Products grew 4.1%. Fragrances and haircare were the main category drivers, skincare showed early signs of recovery, and e-commerce expanded by double digits across regions.

Acquisition Impact, Outlook, and Market Reaction

The Kering Beauté acquisition, completed on March 31, added about 1.5 percentage points to first-quarter growth. Management highlighted a stepped-up innovation plan and a multi-polar model as drivers of confidence, maintaining optimism for another year of sales and profit growth despite geopolitical and macroeconomic uncertainties. CEO Nicolas Hieronimus said, "L'Oreal is off to a great start."

Currency exchange rates posed a 5.5% headwind in the quarter. The company noted that if rates as of March 31 persist, currency would reduce full-year growth by about 1.3 percentage points.

Shares rose roughly 8–9% on April 23, 2026, marking the strongest single-day gain since 2008. JPMorgan raised its full-year sales-growth forecast to 4.8% from 4.1% after the results. Post-earnings consensus centers near 5.0% organic growth for 2026 with a modest 0.1 percentage point improvement in operating margin.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI employee arrested after a hidden device was discovered; company says models identified installer and found no data loss easing investor risk.

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital convertible notes proposal would raise $850 million and include a concurrent exchange, raising dilution concerns and pressuring shares.

Character.AI Bankruptcy Draws Disney Interest

Character.AI Bankruptcy Draws Disney Interest

Character.AI bankruptcy starts a Section 363 sale with Disney as stalking-horse and $20 million bid, compressing the auction and shaping recoveries.

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile downgrade after Piper Sandler cut its target, citing launch pace doubts and SpaceX competition, tightening trader positioning.

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia incident triggered precautionary coaster closures and state reviews, raising near-term operational risk to attendance and shares.

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 earnings raised guidance to a $101.2 billion sales midpoint while MedTech weakness may force traders to reprice device risk.